Video Experimental Relacionado

Updated: Apr 7, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

Síntesis total de la shishijimicina A

K C Nicolaou¹, Zhaoyong Lu¹, Ruofan Li¹

¹Department of Chemistry, Rice University, 6100 Main Street, Houston, Texas 77005, United States.

Journal of the American Chemical Society

|July 3, 2015

Resumen

Los investigadores lograron la síntesis total de la shishijimicina A, un potente agente antitumoral. Esto se logró utilizando una estrategia convergente con los intermediarios clave, el disacárido de carbolina e hidroxienediina tioacetato.

Área de la Ciencia:

Química orgánica es la química orgánica.
Química Medicinal La Química Medicinal es un campo de estudio de la química medicinal.
Descubrimiento de Drogas Descubrimiento de Drogas

Sus antecedentes:

La shishijimicina A es un producto natural raro con un potencial antitumoral significativo.
La estructura compleja de la shishijimicina A presenta un desafío sintético considerable.

Objetivo del estudio:

Desarrollar una síntesis total robusta y eficiente de la shishijimicina A.
Proporcionar acceso a la shishijimicina A para una mayor evaluación biológica y potencial desarrollo terapéutico.

Principales métodos:

Empleó una estrategia convergente sintética.
Los componentes clave utilizados fueron el disacárido de carbolina (3) y el tioacetato de hidroxienediina (4).

Principales resultados:

Se completó con éxito la síntesis total de la shishijimicina A.
El enfoque convergente facilitó el ensamblaje de la compleja arquitectura molecular.

Conclusiones:

La vía sintética desarrollada es viable para producir shishijimicin A.
Esta síntesis allana el camino para explorar las aplicaciones terapéuticas de este potente agente antitumoral.

Más Videos Relacionados

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028

Published on: January 13, 2017

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Published on: October 2, 2018

Videos de Conceptos Relacionados

Biosynthesis in Bacteria

Biosynthesis in Bacteria

Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...

Production of Antibiotics

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...

Peptidoglycan Synthesis

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...